We are live on ! Find out more
LBPSW

4D Pharma PLC Warrant
LBPSW

Delisted

LBPSW was delisted on the 29th of June, 2022.

Back to rankings

8 hedge funds and large institutions have $1.19M invested in 4D Pharma PLC Warrant in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
+$689K
2
AA
AQR Arbitrage
Connecticut
+$156K
3
HF
HRT Financial
New York
+$84K
4
YCM
Yakira Capital Management
Connecticut
+$62.6K
5
BFM
Boothbay Fund Management
New York
+$33.3K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
KPF
1
K2 Principal Fund
Ontario, Canada
$601K +$689K +550,944 New
BFM
2
Boothbay Fund Management
New York
$315K +$33.3K +26,600 New
AA
3
AQR Arbitrage
Connecticut
$136K +$156K +125,000 New
HF
4
HRT Financial
New York
$73K +$84K +67,158 New
YCM
5
Yakira Capital Management
Connecticut
$55K +$62.6K +50,000 New
HIM
6
HGC Investment Management
Ontario, Canada
$6K +$6.35K +5,072 New
UBS Group
7
UBS Group
Switzerland
$5K +$6.06K +4,845 New
WAM
8
Wolverine Asset Management
Illinois
– +$976 +780 New

LBPSW Hedge Fund Activity: Q1 2021 in Review

8 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q1 2021, worth a combined $1.19M.

Buyers outnumbered sellers: 8 funds opened new LBPSW positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was K2 Principal Fund, opening a new position worth an estimated $689K.

  • 8 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $1.19M of 4D Pharma PLC Warrant stock for Q1 2021.
  • 8 funds opened new 4D Pharma PLC Warrant positions in Q1 2021 and 0 closed out, a net change of +8 holders.
  • The largest 4D Pharma PLC Warrant buyer in Q1 2021 was K2 Principal Fund, an estimated $689K added.

Based on aggregated 13F filings for Q1 2021.